BCAX — Bicara Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Broadcom, JPMorgan, Enpro
U.S. STOCKS ON THE MOVE-Bloom Energy, Argan, Endra Life Sciences
Bicara Therapeutics climbs after FDA's 'breakthrough' tag for cancer therapy
Brief: Bicara Therapeutics Files For Mixed Shelf Offering Of Up To $400 Million - SEC Filing
Brief: Relay Therapeutics Appoints Claire Mazumdar To Board Of Directors
Brief: Bicara Therapeutics Inc QTRLY Loss Per Share $0.39
U.S. RESEARCH ROUNDUP-Conmed, McKesson, Veralto
Third Rock-backed Maze Therapeutics reveals profit in US IPO filing
Goldman-backed drug developer Septerna targets $743 mln valuation in upsized US IPO (updated)
TPG-backed CeriBell seeks up to $578 mln valuation in upsized US IPO (updated)
Brief: Ra Capital Management Lp Reports 12.8% Stake In Bicara Therapeutics As Of Sept 16 - SEC Filing
TPG-backed Bicara Therapeutics soars in Nasdaq market debut
TPG-backed Bicara Therapeutics shares surge 46% in stellar market debut (updated)
TPG-backed Bicara Therapeutics shares jump 45.8% in stellar market debut
TPG-backed Bicara Therapeutics raises $315 mln in US IPO (updated)
TPG-backed Bicara Therapeutics raises $315 mln in US IPO
Brief: Bicara Therapeutics Announces Pricing Of Upsized Initial Public Offering